Anti-Rheumatics Market Size, Share, Growth, and Forecast to 2032

Global Anti-Rheumatics Market: Insights

According to the report published by Zion Market Research, the global Anti-Rheumatics Market size was valued at USD 65.24 Billion in 2023 and is predicted to reach USD 82.92 Billion by the end of 2032. The market is expected to grow with a CAGR of 2.7% during the forecast period. The report analyzes the global Anti-Rheumatics Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Anti-Rheumatics industry.

Request Free Sample

Global Anti-Rheumatics Market: Overview

Rheumatoid arthritis is a medical disorder that is indicated by the presence of swollen, warm, and painful joints. The disease affects both the hand and wrist of the person. Rheumatoid arthritis disorder continuously proliferates over a period of time. The treatment is done using various drugs known as anti-rheumatic. Such drugs are known to modify the course of medical conditions. However, the disease-modifying anti-rheumatic drugs are the ones that slow down the spread and progression of the disease. Different drugs like anti-inflammatory and non-steroidal drugs are utilized in the treatment process of rheumatoid arthritis.

Global Anti-Rheumatics Market: Growth Factors

The easy availability of novel biologics along with the growing reliable clinical treatments is one of the major factors driving the growth of the global anti-rheumatics market vigorously. The growing awareness among people regarding safer drugs is the key reason inclining patients toward the anti-rheumatics. However, the disease is continuously progressing rapidly all across the globe.

Thus, the government regulatory bodies and the prominent market players are boosting their funding to develop effective drugs against rheumatoid arthritis to lower its incidences all over the world. Also, the presence of biologics and biosimilars along with the increasing acceptance of biopharmaceuticals is likely to trigger the growth of the market during the forecast period. The emergence of combination therapy to provide advanced and positive results to patients is expected to positively shape the trajectory of the global anti-rheumatics market during the forecast period.

Key Insights

• As per the analysis shared by our research analyst, the global Anti-Rheumatics Market is estimated to grow annually at a CAGR of around 2.7% over the forecast period (2024-2032).
• In terms of revenue, the global Anti-Rheumatics Market size was valued at around USD 65.24 Billion in 2023 and is projected to reach USD 82.92 Billion by 2032.
• Based on the sales channel, In the anti-rheumatics market, the hospital pharmacies segment holds the most dominant position by sales channel. This is primarily due to the high rate of prescriptions for chronic conditions like rheumatoid arthritis that require continuous medical supervision and administration of biologics or DMARDs (disease-modifying anti-rheumatic drugs), which are often dispensed through hospitals. Additionally, hospitals tend to have better infrastructure for administering advanced therapies, further reinforcing their dominance in this segment.
• Based on the molecule type, When segmented by molecule type, biologics represent the most dominant segment in the anti-rheumatics market. Biologics have gained significant traction due to their targeted action, higher efficacy, and fewer side effects compared to traditional synthetic DMARDs. Their adoption has increased rapidly with the rise in autoimmune disease prevalence and growing patient awareness, despite their relatively higher cost.
• Based on the region, North America dominates the anti-rheumatics market. The region benefits from a high prevalence of arthritis-related conditions, advanced healthcare infrastructure, strong reimbursement policies, and robust R&D activities. The presence of major pharmaceutical companies and high patient awareness further support North America’s leading position in this market.

Anti-Rheumatics Market: Report Scope

Global Anti-Rheumatics Market: Segmentation

Request Free Sample​

The global anti-rheumatics market can be segmented into the sales channel, molecule type, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

By sales channel, the market can be segmented into over-the-counter and prescription. The prescription segment accounts for the largest share in the global anti-rheumatics market due to the growing awareness among patients regarding advanced disease reversal treatment methods and techniques. Also, the growing consultations for rheumatoid arthritis by medical professionals are likely to further augment the growth of the segment in the forthcoming years. However, the growing adverse effect of over-the-counter medication in patients also fueled the growth of the segment. However, the continuous intake of over-the-counter medication for pain management leads to liver damage and medication addiction which is also likely to promulgate the growth of the segment.

By molecule type, the market can be segmented into biopharmaceutical and pharmaceuticals. The pharmaceutical segment can further be bifurcated into glucocorticoids, DMARDs, analgesics, and NSAIDs. The biopharmaceutical segment is further bifurcated into biosimilars and biologics. The biopharmaceuticals segment holds the largest share in the global anti-rheumatics market due to the growing number of novel biotherapies and treatments for rheumatoid arthritis. However, the pharmaceutical segment is also expecting to grow vigorously during the forecast period due to the fact that it is considered a first-line treatment for such medical disorders. The biologics segment holds hegemony over others. The biologics segment is further categorized into anti-IL 6 biologics, JAK inhibitors, CD20 antigen, T-cell inhibitors, and TNF-α antagonists.

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Global Anti-Rheumatics Market: Regional analysis

Request Free Sample

North America accounts for the largest share in the global anti-rheumatics market due to the growing awareness among patients regarding the easy availability of effective treatments in the region. Moreover, the growing incidences of rheumatoid arthritis in the region will further augment the growth of the regional market in the forthcoming years. Also, the growing expenditure from the governments as well as the prominent market players to strengthen the healthcare infrastructure is further likely to stimulate the growth of the regional market.

Asia Pacific is anticipated to witness significant growth during the forecast period due to the high adoption of urbanic lifestyle among people in the region.

Global Anti-Rheumatics Market: Competitive Players

Some of the significant players in the global anti-rheumatics market are

• Amgen Inc.
• Celltrion Inc.
• Biogen Inc.
• Takeda Pharmaceutical Company Ltd.
• MedImmune
• LLC
• Celgene Corporations
• F. Hoffmann-La Roche Ltd.
• Bristol-Myers Squibb Company
• Johnson & Johnson
• Pfizer, Inc.

The Global Anti-Rheumatics Market segments are as follows:

By Sales Channel

• Over-the-counter
• Prescription

By Molecule Type

• Biopharmaceutical
• Pharmaceuticals

Global Anti-Rheumatics Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.